Mn Services Vermogensbeheer B.V. Has $6.73 Million Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Mn Services Vermogensbeheer B.V. decreased its position in Avantor, Inc. (NYSE:AVTR) by 2.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 260,300 shares of the company’s stock after selling 5,500 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Avantor were worth $6,734,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. National Pension Service raised its position in Avantor by 5.7% in the third quarter. National Pension Service now owns 1,288,319 shares of the company’s stock worth $33,329,000 after purchasing an additional 69,818 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in shares of Avantor by 45.3% in the third quarter. Robeco Institutional Asset Management B.V. now owns 86,225 shares of the company’s stock worth $2,231,000 after acquiring an additional 26,884 shares during the last quarter. Norris Perne & French LLP MI lifted its holdings in Avantor by 0.6% during the 3rd quarter. Norris Perne & French LLP MI now owns 491,696 shares of the company’s stock worth $12,720,000 after buying an additional 2,876 shares in the last quarter. US Bancorp DE lifted its stake in shares of Avantor by 6.2% during the third quarter. US Bancorp DE now owns 12,615 shares of the company’s stock valued at $326,000 after acquiring an additional 734 shares during the period. Finally, New York State Teachers Retirement System acquired a new position in Avantor during the 3rd quarter valued at about $8,473,000. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

NYSE AVTR opened at $22.97 on Thursday. Avantor, Inc. has a 12-month low of $18.08 and a 12-month high of $28.00. The firm has a 50-day moving average price of $25.03 and a two-hundred day moving average price of $24.14. The company has a market capitalization of $15.63 billion, a P/E ratio of 49.93, a P/E/G ratio of 2.70 and a beta of 1.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Barclays decreased their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Morgan Stanley increased their target price on Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Citigroup downgraded shares of Avantor from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. Robert W. Baird reduced their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Finally, UBS Group dropped their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and an average target price of $27.57.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.